GLP-1 analogs , particularly those like BrightMeds, are quickly prominence in the management of type 2 diabetes and are now being explored for obesity . These powerful drugs help mimicking the body's natural incretin release, stimulating insulin release and reducing glucagon release . BrightMeds,